It is well known that caspase-2 acts as a tumor suppressor in many cancers, including lung cancer [39], whereas p62 overexpression and/or its reduced degradation is commonly associated with tumor formation, cancer promotion, and resistance to therapy [40]. This evidence concerns the gene CASP2 and lung cancer.